OPERATING AND REPORTABLE SEGMENTS (Tables)

3 Months Ended

Mar. 31, 2014

Segment Reporting [Abstract]

Schedule of Segment Reporting Information, by Segment

Segment Reporting Information

(in thousands)

	Three Months Ended March 31,
	2014			2013
Results of Operations:
Revenue:
Infusion Services - product revenue	$	215,900		$	150,024
Infusion Services - service revenue	5,519			4,353
Total Infusion Services revenue	221,419			154,377
PBM Services - service revenue	18,224			26,752
Total revenue	$	239,643		$	181,129
Adjusted EBITDA by Segment before corporate overhead:
Infusion Services	$	14,853		$	11,909
PBM Services	1,675			6,195
Total Segment Adjusted EBITDA	16,528			18,104
Corporate overhead	(7,476		)	(7,916		)
Interest expense, net	(10,499		)	(6,478		)
Income tax (expense) benefit	(3,491		)	224
Depreciation	(3,836		)	(2,418		)
Amortization of intangibles	(1,703		)	(2,082		)
Stock-based compensation expense	(2,886		)	(1,973		)
Acquisition and integration expenses	(6,499		)	(4,623		)
Restructuring and other expenses and investments	(5,560		)	(1,279		)
Loss from continuing operations, net of income taxes	$	(25,422	)	$	(8,441	)
Supplemental Operating Data
	March 31, 2014			December 31, 2013
Total Assets:
Infusion Services	$	808,871		$	793,475
PBM Services	31,475			25,239
Corporate unallocated, including cash and cash equivalents	59,714			53,169
Assets from discontinued operations	—			64,959
Assets associated with discontinued operations, not sold	16			16
Total Assets	$	900,076		$	936,858